|
The level of hemophilia care has significantly improved over the last few decades. Despite all improvements, the development and management of neutralizing antibodies i.e. inhibitors remains a major complication to treatment with factor concentrates.
AIM OF THE COURSE
The aim of this course is to summarize and highlight the current pre-clinical and
clinical knowledge in the inhibitor area in an interactive way based on lectures and
case discsussions.
TARGET GROUP
Physicians treating hemophilia from all over the world. Participants should be affiliated to a hemophilia centre, have been working in the area for at least one year and have a proven future commitment to this field.
Good English-speaking skills are required.
|